Abstract
The term "aspirin intolerance" is defined as acute urticaria-angioedema, bronchospasm, severe rhinitis, or shock occurring within three hours of aspirin ingestion. Aspirin intolerance occurs most commonly in patients with chronic urticaria (23%), in whom it is mostly manifested by the urticaria type of aspirin tolerance, and in asthmatic individuals (4%), in whom it is mostly manifested by the bronchospastic type. There is no definite evidence that aspirin intolerance is mediated by an immunologic reaction. In the bronchospastic type, an association between prostaglandins and the slow-reacting substance of anaphylaxis (SRS-A) seems likely. It is possible that aspirin causes a preponderance of prostaglandin F2 alpha (PGF2 alpha), resulting in bronchospasm. The effect of aspirin on blood histamine is controversial. The two major types of aspirin intolerance seem to be mediated by different mechanisms.
Citations
Aug 1, 1997·Archives of Pharmacal Research·S J LeeJ S Ahn
Sep 29, 2001·Anaesthesia·R D MacPherson
Jan 1, 1990·European Journal of Clinical Pharmacology·L Van Diem, J P Grilliat
May 12, 2009·Prostaglandins & Other Lipid Mediators·Joseph H Butterfield
Nov 1, 1985·Seminars in Arthritis and Rheumatism·C L Malmsten
Apr 1, 1984·Allergy·M L KowalskiM Szmidt
Feb 1, 1985·Allergy·M L KowalskiJ Rozniecki
Jul 8, 2009·Current Medical Research and Opinion·Glenis Scadding
Jan 1, 1984·Scandinavian Journal of Rheumatology. Supplement·C Malmsten
Dec 1, 1991·AORN Journal·V A Goins
Mar 5, 2003·Journal of Neurochemistry·Jeffrey N StuartJonathan V Sweedler
May 2, 1985·European Journal of Biochemistry·J Meijer, J W Depierre
Feb 22, 2012·Journal of Bacteriology·A L Gallego-HernándezE Calva
Jan 1, 1996·Pharmacology & Toxicology·K Dalhoff